Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema

被引:62
作者
Hartley, Kristen L. [1 ]
Smiddy, William E. [1 ]
Flynn, Harry W., Jr. [1 ]
Murray, Timothy G. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33101 USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2008年 / 28卷 / 03期
关键词
diabetic macular edema; internal limiting membrane; macular edema; vitrectomy;
D O I
10.1097/IAE.0b013e31816102f2
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose: To evaluate anatomic and visual acuity (VA) results of pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling for diffuse diabetic macular edema (DME), and to review the literature on the topic. Methods: Retrospective noncomparative case series of patients who underwent PPV with ILM peeling for diffuse DME between January 1, 2000, and December 1, 2005, performed by three surgeons at Bascom Palmer Eye Institute. Main outcome measures included pre- and postoperative optical coherence tomography (OCT) and visual acuity. Mean follow-up period was 8 months (range, 43 days-2 years). Results: Twenty-four eyes of 23 patients meeting the criteria were evaluated. Duration of DME ranged from 1 to 93 months. Mean preoperative logMAR vision was 0.782 (range, 0.30-1.82). Mean logMAR visual acuity at final follow-up was 0.771 (range, 0.10-2.00). At last follow-up, 25% of eyes had >= 2 line increase in VA from baseline, 54% of eyes had no improvement in VA, and 21% of eyes had >= 2 line decrease in VA. Of 9 eyes with pre- and postoperative OCT, there was an overall reduction in central macular thickness of 141 mu m at postoperative month 3 and 120 mu m at last follow-up. Postoperative complications included progression of cataract in 6 (60%) of 10 phakic eyes, postoperative intraocular pressure >= 30 mmHg in 6 (24%) eyes, and postoperative vitreous hemorrhage in 2 (8%) eyes. Conclusions: Pars plana vitrectomy with ILM peeling was associated with a reduction in DME when measured by OCT in the majority of eyes, but visual acuity outcomes showed minimal improvement compared to baseline. These results suggest the efficacy of PPV with ILM peeling for eyes with DME has not been well established and should be reserved for therapy with selected cases.
引用
收藏
页码:410 / 419
页数:10
相关论文
共 83 条
[1]
Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial [J].
Audren, Francois ;
Erginay, Ali ;
Haouchine, Belkacem ;
Benosman, Rym ;
Conrath, John ;
Bergmann, Jean-Francois ;
Gaudric, Alain ;
Massin, Pascale .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (05) :624-630
[2]
A new surgical approach for indocyanine green-assisted internal limiting membrane peeling [J].
Avci, R ;
Avci, B ;
Kaderli, B ;
Cavusoglu, I .
OPHTHALMIC SURGERY LASERS & IMAGING, 2004, 35 (04) :292-297
[3]
Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema [J].
Avci, R ;
Kaderli, B ;
Avci, B ;
Simsek, S ;
Baykara, M ;
Kahveci, Z ;
Gelisken, O ;
Yucel, AA .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (10) :845-852
[4]
Bahadir Mehmet, 2005, International Ophthalmology, V26, P3
[5]
Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema [J].
Bardak, Y. ;
Cekic, O. ;
Tig, S. U. .
EYE, 2006, 20 (12) :1357-1359
[6]
Macular hole surgery with and without internal limiting membrane peeling [J].
Brooks, HL .
OPHTHALMOLOGY, 2000, 107 (10) :1939-1948
[7]
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema [J].
Browning, David J. ;
Glassman, Adam R. ;
Aiello, Lloyd Paul ;
Beck, Roy W. ;
Brown, David M. ;
Fong, Donald S. ;
Bressler, Neil M. ;
Danis, Ronald P. ;
Kinyoun, James L. ;
Nguyen, Quan Dong ;
Bhavsar, Abdhish R. ;
Gottlieb, Justin ;
Pieramici, Dante J. ;
Rauser, Michael E. ;
Apte, Rajendra S. ;
Lim, Jennifer I. ;
Miskala, Pdivi H. ;
Solomon, Sharon D. ;
Bressler, Susan ;
Finkelstein, Daniel ;
Gehlbach, Peter L. ;
Nguyen, Quan Dong ;
Sung, Jennifer U. ;
Zimmer-Galler, Ingrid ;
Doll, Warren ;
Donohue, Deborah ;
Jurao, Robert ;
Sheehan, Siobhan E. ;
Belt, Judith ;
Sharuk, George S. ;
Arrigg, Paul G. ;
Schlossman, Deborah K. ;
Shah, Sabera T. ;
Kopple, Ann ;
Stockman, Margaret E. ;
Bestourous, Leila ;
Calderon, Richard M. ;
Cavallerano, Jerry D. ;
Chau, Tak ;
Cavicchi, Robert W. ;
Strong, James ;
Wells, John A. ;
Clark, Lloyd ;
Bearden, Ruth T. ;
Taylor, Mallie M. ;
Spivey, Robbin ;
Evans, Mark A. ;
Stone, Marsha L. ;
Gardner, Thomas W. ;
Neely, Kimberly A. .
OPHTHALMOLOGY, 2007, 114 (03) :525-536
[8]
Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema [J].
Chan, C. K. M. ;
Mohamed, S. ;
Shanmugam, M. P. ;
Tsang, C. -W ;
Lai, T. Y. Y. ;
Lam, D. S. C. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (09) :1137-1141
[9]
A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema [J].
Chun, Dal W. ;
Heier, Jeffrey S. ;
Topping, Trexler M. ;
Duker, Jay S. ;
Bankert, Joy M. .
OPHTHALMOLOGY, 2006, 113 (10) :1706-1712
[10]
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema [J].
Cunningham, ET Jr ;
Adamis, AP ;
Altaweel, M ;
Aiello, LP ;
Bressler, NM ;
D'Amico, DJ ;
Goldbaum, M ;
Guyer, DR ;
Katz, B ;
Patel, M ;
Schwartz, SD .
OPHTHALMOLOGY, 2005, 112 (10) :1747-1757